Urovant Sciences Ltd. (UROV) News
Filter UROV News Items
UROV News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest UROV News From Around the Web
Below are the latest news stories about Urovant Sciences Ltd that investors may wish to consider to help them evaluate UROV as an investment opportunity.
NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith, LLC Reminds Investors of Investigations Related to the Following Companies: Urovant Sciences Ltd. (Nasdaq - UROV), Cubic Corporation (NYSE - CUB), CoreLogic, Inc. (NYSE - CLGX)BALA CYNWYD, PA / ACCESSWIRE / February 13, 2021 / Brodsky & Smith, LLC reminds investors of investigations it is conducting regarding the following companies for possible breaches of fiduciary duty and other violations of federal and state law .Brodsky & Smith, LLCBALA CYNWYD, PA / ACCESSWIRE / February 13, 2021 / Brodsky & Smith, LLC reminds investors of investigations it is conducting regarding the following companies for possible breaches of fiduciary duty and other violations of federal and state law with respect to proposed acquisition transactions. |
Urovant Sciences Provides Merger Update and Reports Third Quarter Fiscal Year 2020 ResultsUrovant Sciences Provides Merger Update and Reports Third Quarter Fiscal Year 2020 Results |
INVESTIGATION ALERT: Halper Sadeh LLP Investigates MDCA, NHLD, COHR, UROV; Shareholders Are Encouraged to Contact the FirmNEW YORK, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: MDC Partners Inc. (NASDAQ: MDCA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Stagwell Media LP. Stagwell and its affiliates are expected to hold approximately 79% of the common equity of the combined company after closing. If you are an MDC shareholder, click here to learn more about your rights and options. National Holdings Corporation (NASDAQ: NHLD) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to B. Riley Financial, Inc. for $3.25 per share. If you are a National Holdings shareholder,... |
Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders Are Encouraged to Contact the Firm - CPAH, UROV, ANH, CGIX, CBLI, NEOSHalper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: |
SHAREHOLDER ALERT: WeissLaw LLP Reminds JWS, BRPA, and UROV Shareholders About Its Ongoing InvestigationsIf you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: |
INVESTIGATION ALERT: Halper Sadeh LLP Investigates COHR, CBMG, WTRE, NAV, UROV; Shareholders Are Encouraged to Contact the FirmHalper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: |
Lifshitz Law Firm, P.C. Announces Investigation of CBMG, HMSY, UROV, and WDRNEW YORK, NY / ACCESSWIRE / January 18, 2021 / Lifshitz Law Firm, P.:Cellular Biomedicine Group, Inc. |
ALERT: Halper Sadeh LLP Reminds Investors of Its Ongoing Merger Investigations; Shareholders are Encouraged to Contact the Firm – CBMG, CGIX, UROVNEW YORK, Jan. 16, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to a consortium that includes members of Cellular Biomedicine management and several entities. If you are a Cellular Biomedicine shareholder, click here to learn more about your rights and options. Cancer Genetics, Inc. (NASDAQ: CGIX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with StemoniX, Inc. Under the merger agreement, Cancer Genetics will acquire all of the outstanding capital stock of StemoniX... |
SHAREHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following MergerJuan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating: |
INVESTIGATION ALERT: Halper Sadeh LLP Investigates FFG, NHLD, HCAP, NAV, UROV; Shareholders Are Encouraged to Contact the FirmHalper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: |